Trevor Hackman
Overview
Explore the profile of Trevor Hackman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
50
Citations
975
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kim S, Tasoulas J, Sheth S, Yarbrough W, Hackman T, Amelio A, et al.
Ear Nose Throat J
. 2025 Feb;
:1455613251324353.
PMID: 40018983
Salivary gland cancer (SGC) comprises a very heterogeneous group of rare neoplasms, accounting for approximately 2% to 6% of head and neck malignancies. Surgery with or without adjuvant radiotherapy is...
2.
Farquhar D, Lenze N, Tasoulas J, Sheth S, Zevallos J, Lumley C, et al.
Transl Cancer Res
. 2024 Oct;
13(9):5050-5063.
PMID: 39430853
Background: Differences in patient populations and outcomes by hospital type are becoming increasingly relevant as health care systems shift to value-based care models. There is a paucity of literature on...
3.
AlQudah L, Hackman T, Brownlee A
Head Neck Pathol
. 2024 Jun;
18(1):53.
PMID: 38896312
Mixed neuroendocrine-nonneuroendocrine (MiNEN) neoplasms in the head and neck are exceptionally rare biphasic tumors with unclear pathogenesis and an aggressive clinical behavior. This is the first reported case of an...
4.
Tasoulas J, Adams G, Schrank T, Agala C, Sheth S, Yarbrough W, et al.
Oral Oncol
. 2024 Jun;
155:106879.
PMID: 38852232
No abstract available.
5.
Tasoulas J, Farquhar D, Sheth S, Hackman T, Yarbrough W, Agala C, et al.
J Natl Cancer Inst
. 2023 Sep;
116(1):105-114.
PMID: 37725515
Background: Poor oral health has been identified as a prognostic factor potentially affecting the survival of patients with head and neck squamous cell carcinoma. However, evidence to date supporting this...
6.
Tasoulas J, Schrank T, Smith B, Agala C, Kim S, Sheth S, et al.
Oral Oncol
. 2023 Aug;
146:106535.
PMID: 37625360
Objectives: The delivery of healthcare has changed significantly over the past decades. This study analyzes the clinicodemographic factors and treatment patterns of head and neck squamous cell carcinoma (HNSCC) patients...
7.
Patel S, Gibson M, Deal A, Sheth S, Heiling H, Johnson S, et al.
Cancer
. 2023 Jul;
129(21):3381-3389.
PMID: 37395170
Background: Patients with locally advanced head and neck squamous cell cancer (HNSCC) are treated with surgery followed by adjuvant (chemo) radiotherapy or definitive chemoradiation, but recurrence rates are high. Immune...
8.
Morse R, Beaty B, Scanga L, Blumberg J, Patel S, Yarbrough W, et al.
Oral Oncol
. 2022 Oct;
135:106212.
PMID: 36274024
No abstract available.
9.
Morse R, Beaty B, Scanga L, Blumberg J, Patel S, Yarbrough W, et al.
Oral Oncol
. 2022 Oct;
134:106131.
PMID: 36191480
Purpose/objective(s): Accurate diagnosis of human papillomavirus (HPV) status in oropharyngeal squamous cell carcinoma (OPSCC) affects prognosis and can alter the treatment plan. We evaluated the diagnostic accuracy of FNA biopsies...
10.
Sheth S, Gilbert J, Deal A, Chera B, Murphy B, Woods J, et al.
Oral Oncol
. 2022 Mar;
127:105807.
PMID: 35263677
No abstract available.